Cladis Investment Advisory »

Biogen Idec shares owned by Cladis Investment Advisory

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Cladis Investment Advisory from 13F filings

Historical chart of Cladis Investment Advisory investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Cladis Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Cladis Investment Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $183k 1.0k 175.99

More positions owned by Cladis Investment Advisory

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Ge Aerospace Com New (GE)
Invesco Qqq Tr Unit Ser Q (QQQ)
Select Sector Spdr Tr Technology (XLK)
International Business Machines (IBM)
Ge Vernova (GEV)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
First Intst Bancsystem Com Cl A (FIBK)
Costco Wholesale Corporation (COST)
Caterpillar (CAT)
Exxon Mobil Corporation (XOM)

View all positions for Cladis Investment Advisory

Top funds holding Biogen Idec

Vanguard Group
BlackRock
PRIMECAP Management Company
State Street Corporation
Wellington Management Company
Geode Capital Management
Point72 Asset Management
Norges Bank Investment Management
Susquehanna International
AQR Capital Management
Robeco Investment Management
Invesco
Barclays
Legal & General Group
Millennium Management

View all funds holding Biogen Idec